Comparison of incidence/'risk of venous thromboembolism (VTE) among selected clinical and hereditary risk markers: A community-based cohort study

被引：20

作者：

Spannagl M. ^{[1
]}

Heinemann L.A.J. ^{[2
]}

DoMinh T. ^{[2
]}

Assmann A. ^{[2
]}

Schramm W. ^{[1
]}

Schürmann R. ^{[3
]}

机构：

[1] Ludwig-Maximillian-University Munich, Klinikum der Universität, Abteilung Haemostasiologe, 80336 Muenchen

[2] Centre for Epidemiology and Health Research Berlin, 10115 Berlin

[3] Schering AG, SBU Fertility Control/Hormone Therapy

来源：

Thrombosis Journal | / 3卷 / 1期

关键词：

Cohort study; Incidence; Inherited and acquired risk factors; Relative risk; Venous thromboembolism;

D O I：

10.1186/1477-9560-3-8

中图分类号：

学科分类号：

摘要：

Background: Little information is available from community-based long-term VTE cohort studies to compare the absolute thrombosis risk of established clinical and genetic risk factors. Materials and methods: The occurrence of venous thromboembolism (VTE) was observed during a 10-year observation period in the BAvarian ThromboEmbolic Risk (BATER) study, a cohort study of 4337 women (age 18-55 years). We collected data on demographics, reproductive life, lifestyle, conditions/diseases, and particularly potential risk factors for VTE with a self-administered questionnaire. The objective was to present incidence rates of VTE and to show relative risk estimated associated with different clinical and genetic risk factors. Results: 34 new, by diagnostic means confirmed VTE events occurred during the observation time of 32,656 women-years (WY). The overall incidence of VTE was 10.4 per 104 WY. The incidence rates varied markedly among different risk cohorts. The highest incidence was observed in women with previous history of VTE, followed by family history of VTE. None of the measured "genetically-related risk markers" (antithrombin, protein C, FVL, prothrombin mutation, or MTHFR) showed a significant VTE risk. Conclusion: Most of the discussed VTE risk factors showed no significant association with the occurrence of new VTEs due to smallness of numbers. Only first-degree family history of VTE and own history of a previous VTE event depicted a significant association with future VTE. Clinical information seems to be more important to determine future VTE risk than genetically related laboratory tests. © 2005 Spannagl et al; licensee BioMed Central Ltd.

引用

页数：10

共 30 条

[1]

Juul K., Tybjaerg-Hansen A., Schnohr P., Nordestgaard B.G., Factor V Leiden and the risk for venous thromboembolism in the adult Danish population, Ann. Intern. Med., 140, pp. 330-337, (2004)

[2]

Schramm W., Heinemann L.A.J., Spannagl M., Dick A., Assmann A., Die BAyerischen Thrombo-Embolie-Risiko Kohortenstudie (BATER). Studienprotokoll, Stand der Untersuchung und erste Ergebnisse, Dtsch. Med. Wschr., 125, pp. 2-6, (2000)

[3]

Spannagl M., Dick A., Assmann A., Heinemann L., Schramm W., Resistance to activated protein C in women using oral contraceptives, Sem. Thrombosis Hemostasis, 24, pp. 423-430, (1998)

[4]

Heinemann L.A.J., DoMinh T., Assmann A., Schramm W., Schuermann R., Hilpert J., Spannagl M., VTE risk assessment - A prognostic model: BATER cohort study of young women, Thrombosis Journal, 3, (2005)

[5]

Endler G., Kyrle P.A., Eichinger S., Exner M., Mannhalter C., Multiplex mutagenically separated PCR: Simultaneous single-tube detection of the Factor V R506Q (G1691A), the Prothrombin G2010A, and the Methylenetetrahydrofolate Reductase A223V (C677T) Variants, Clin. Chem., 47, 2, pp. 333-335, (2001)

[6]

Pabinger I., Brucker S., Kyrle P., Schneider B., Korninger H.C., Niessner H., Lechner K., Hereditary deficiency of antithrombin III, protein C and protein S: Prevalence in patients with a history of venous thrombosis and criteria for rational patient screening, Blood Coagul. Fibrinolyis, 3, pp. 547-553, (1992)

[7]

Farmer R.D.T., Preston T.D., The risk of venous thromboembolism associated with low estrogen oral contraceptives, J. Obstet. Gynaecol., 15, pp. 195-200, (1995)

[8]

Fowkes F.J.I., Price J.F., Fowkes F.G.R., Incidence of diagnosed deep vein thrombosis in the general population: Systematic review, Eur. J. Endovasc. Surg., 25, pp. 1-5, (2003)

[9]

Ridker P.M., Glynn R.J., Miletich J.P., Goldhaber S.Z., Stampfer M.J., Hennekens C.H., Age-specific incidence rates of venous thromboembolism among heterozygous carriers of factor V Leiden mutation, Ann. Intern. Med., 126, pp. 528-531, (1997)

[10]

Baglin T., Luddington R., Brown K., Baglin C., Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: Prospective cohort study, Lancet, 362, pp. 523-526, (2003)

← 1 2 3 →